Literature DB >> 3308510

The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

W J Martone1, O C Tablan, W R Jarvis.   

Abstract

Pseudomonas cepacia has occasionally been identified as an epidemic and endemic nosocomial pathogen. In outbreaks, usually one clinical site predominates but many may be involved. Detailed investigations have usually implicated a contaminated liquid reservoir or moist environmental surface as the source. Liquid sources have included a number of different classes of antiseptics and disinfectants such as quaternary ammonium chlorides, biguanides, hexachlorophene, and iodophors. Environmental and patient isolates have had multiply resistant antimicrobial susceptibility patterns. The clinical distinction between colonization and infection may be difficult and may challenge the skills of the clinician. Expenditure of resources needed to solve epidemics is justified in view of the potential virulence of this organism and the high likelihood that an unrecognized but easily eliminated liquid environmental reservoir may be the source.

Entities:  

Mesh:

Year:  1987        PMID: 3308510     DOI: 10.1007/BF00149728

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  44 in total

1.  Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers.

Authors:  S M Gelbart; G F Reinhardt; H B Greenlee
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

2.  Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant.

Authors:  R L Berkelman; R L Anderson; B J Davis; A K Highsmith; N J Petersen; W W Bond; E H Cook; D C Mackel; M S Favero; W J Martone
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

3.  Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit.

Authors:  I Phillips; S Eykyn; M A Curtis; J J Snell
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

4.  Hospital infection by Pseudomonas cepacia.

Authors:  D C Speller; M E Stephens; A C Viant
Journal:  Lancet       Date:  1971-04-17       Impact factor: 79.321

5.  Pseudomonas cepacia in 16 non-fatal cases of postoperative bacteremia derived from intrinsic contamination of the anaesthetic fentanyl. Clinical and epidemiological observations in Denmark and Holland.

Authors:  K Siboni; H Olsen; E Ravn; P Søgaard; A Hjorth; K N Nielsen; K Askgaard; B Secher; J Borghans; L Khing-Ting; H Joosten; W Frederiksen; K Jensen; N Mortensen; O Sebbesen
Journal:  Scand J Infect Dis       Date:  1979

6.  Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.

Authors:  P C Hardy; G M Ederer; J M Matsen
Journal:  N Engl J Med       Date:  1970-01-01       Impact factor: 91.245

7.  Colonization and infection with Pseudomonas cepacia.

Authors:  G M Ederer; J M Matsen
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

8.  Postoperative urinary-tract infections caused by contaminated irrigating fluid.

Authors:  R G Mitchell; A C Hayward
Journal:  Lancet       Date:  1966-04-09       Impact factor: 79.321

9.  Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices.

Authors:  S L Solomon; H Alexander; J W Eley; R L Anderson; H C Goodpasture; S Smart; R M Furman; W J Martone
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

10.  Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination.

Authors:  J D Sobel; N Hashman; G Reinherz; D Merzbach
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

View more
  12 in total

1.  Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.

Authors:  M Okazaki; T Watanabe; K Morita; Y Higurashi; K Araki; N Shukuya; S Baba; N Watanabe; T Egami; N Furuya; M Kanamori; S Shimazaki; H Uchimura
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Plasmids of Pseudomonas cepacia strains of diverse origins.

Authors:  E Lennon; B T DeCicco
Journal:  Appl Environ Microbiol       Date:  1991-08       Impact factor: 4.792

3.  Efficient management and maintenance of ultrasonic nebulizers to prevent microbial contamination.

Authors:  Yoko Ida; Hiroaki Ohnishi; Kouji Araki; Ryoichi Saito; Shin Kawai; Takashi Watanabe
Journal:  World J Methodol       Date:  2016-03-26

Review 4.  Current status of Pseudomonas cepacia typing systems.

Authors:  C S Rabkin; W R Jarvis; W J Martone
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

Review 5.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

6.  Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak.

Authors:  C F Pegues; D A Pegues; D S Ford; P L Hibberd; L A Carson; C M Raine; D C Hooper
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

Review 7.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 8.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

9.  The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections.

Authors:  W R Jarvis; D Olson; O Tablan; W J Martone
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

10.  A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry.

Authors:  Wei Zhang; Morris Reichlin
Journal:  Clin Dev Immunol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.